HEXABRIX

This brand name is authorized in Brazil, Singapore, Tunisia, South Africa

Active ingredients

The drug HEXABRIX contains a combination of these active pharmaceutical ingredients (APIs):

1 Ioxaglate sodium
UNII HQ43CN02U9 - IOXAGLATE SODIUM
Read about Ioxaglate
2 Ioxaglate meglumine
UNII 75JR975T11 - IOXAGLATE MEGLUMINE
Read about Ioxaglate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
P01CB01 Meglumine antimonate P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01C Agents against leishmaniasis and trypanosomiasis → P01CB Antimony compounds
Discover more medicines within P01CB01
V08AB03 Ioxaglic acid V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 511000401150419, 511000402157417, 511000404151416
Country: SG Health Sciences Authority Identifier(s): 06033P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5640021B, 5640021C
Country: ZA Health Products Regulatory Authority Identifier(s): P/28/131

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.